Get started
Author

Julianne M. O’Daniel

Observed names: J M O'Daniel, J. O’Daniel, JM O'Daniel, JM O’Daniel, Julianne M O'Daniel, Julianne M. O'Daniel, Julianne M. O'daniel, Julianne M. O-Daniel, Julianne O'Daniel, Julianne O‘Daniel, Julianne O’Daniel, Julianne M. O’Daniel, O'Daniel, Julianne, O'Daniel, Julianne M., OʼDaniel, Julianne M., O’Daniel, J., O’Daniel, J.M., O’Daniel, Julianne M.
Observed institutions: University of North Carolina at Chapel Hill, University of North Carolina Health Care, Duke University, Illumina (United States), Duke Medical Center, Walt Disney (United States), UNC Lineberger Comprehensive Cancer Center
ORCID: 0000-0001-5843-4432
Observed ORCID: 0000-0001-5843-4432
OpenAlex ID: A5047038540
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
2013 · Robert C. Green, Jonathan S. Berg, et al. · Genetics in Medicine · 2,541
PDF
Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource
2017 · Natasha T. Strande, Erin Rooney Riggs, et al. · The American Journal of Human Genetics · 567
PDF
Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between
2014 · Gail P. Jarvik, Laura M. Amendola, et al. · The American Journal of Human Genetics · 369
PDF
A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation
2016 · Jessica Ezzell Hunter, Stephanie A. Irving, et al. · Genetics in Medicine · 149
PDF
Survey of US public attitudes toward pharmacogenetic testing
2011 · S B Haga, J M O'Daniel, et al. · The Pharmacogenomics Journal · 148
PDF
Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)
2021 · Catherine Rehder, Lora J.H. Bean, et al. · Genetics in Medicine · 141
PDF
Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project
2020 · Tamara S. Roman, Stephanie B. Crowley, et al. · The American Journal of Human Genetics · 129
PDF
A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing
2015 · Jonathan S. Berg, Ann Katherine M. Foreman, et al. · Genetics in Medicine · 97
PDF
Germline Analysis from Tumor–Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings
2016 · Bryce A. Seifert, Julianne M. O'Daniel, et al. · Clinical Cancer Research · 95
A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories
2016 · Julianne M. O’Daniel, Heather M. McLaughlin, et al. · Genetics in Medicine · 88
PDF
ClinGen Variant Curation Interface: a variant classification platform for the application of evidence criteria from ACMG/AMP guidelines
2022 · Christine G. Preston, Matt W. Wright, et al. · Genome Medicine · 80
PDF
Public Perspectives on Returning Genetics and Genomics Research Results
2011 · J. O’Daniel, S.B. Haga · Public Health Genomics · 80
An Age-Based Framework for Evaluating Genome-Scale Sequencing Results in Newborn Screening
2019 · Laura V. Milko, Julianne M. O'Daniel, et al. · The Journal of Pediatrics · 79
Genomic Risk Profiling: Attitudes and Use in Personal and Clinical Care of Primary Care Physicians Who Offer Risk Profiling
2011 · Susanne B. Haga, Madeline M. Carrig, et al. · Journal of General Internal Medicine · 79
PDF
Public Perspectives Regarding Data-Sharing Practices in Genomics Research
2011 · S.B. Haga, J. O’Daniel · Public Health Genomics · 68
PDF
Public Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings
2011 · Susanne B. Haga, Genevieve Tindall, et al. · Genetic Testing and Molecular Biomarkers · 67
Professional Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings
2011 · Susanne B. Haga, Genevieve Tindall, et al. · Genetic Testing and Molecular Biomarkers · 58
The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation
2022 · Kimberly Foss, Julianne O’Daniel, et al. · Journal of Personalized Medicine · 57
PDF
Parents’ perceptions of personal utility of exome sequencing results
2019 · Lonna Mollison, Julianne M. O’Daniel, et al. · Genetics in Medicine · 55
PDF
Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing
2012 · SB Haga, JM O'Daniel, et al. · Clinical Genetics · 54
PDF
The Prospect of Genome‐guided Preventive Medicine: A Need and Opportunity for Genetic Counselors
2010 · Julianne M. O'Daniel · Journal of Genetic Counseling · 54
PDF
Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions
2011 · Susanne B. Haga, Julianne M. O’Daniel, et al. · Genetics in Medicine · 53
Examining access to care in clinical genomic research and medicine: Experiences from the CSER Consortium
2021 · Amanda M. Gutierrez, Jill O. Robinson, et al. · Journal of Clinical and Translational Science · 45
PDF
Evidence‐based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group
2018 · Elizabeth M. Webber, Jessica Ezzell Hunter, et al. · Human Mutation · 42
PDF
Is “incidental finding” the best term?: a study of patients’ preferences
2016 · Nina Tan, Laura M. Amendola, et al. · Genetics in Medicine · 42
PDF
Works count: 186
Citation count: 5,922
H-index: 31
I10-index: 49
Year
Topic
Type